TechnologyPatent OppositionCompetitive Analysis

Explore the competitive field of Metabolic Drugs where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in Metabolic Drugs technology and learn how to protect your intellectual property.

Get Patent Opposition Report for Metabolic Drugs

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Report

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the Metabolic Drugs industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the Metabolic Drugs industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition DateOpposition Name

Get alerts on new patent oppositions in the Metabolic Drugs industry

Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAJul 23, 2025ARROWHOUSE
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 16, 2025TEVA PHARMACEUTICALS
Treatment Of Cancer By Manipulation Of Commensal MicrofloraTHE UNIVERSITY OF CHICAGOJul 16, 2025HGF
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 15, 2025MAIWALD
Anticancer CompositionsARAGON PHARMACEUTICALSJul 9, 2025EIP
Anticancer CompositionsARAGON PHARMACEUTICALSJul 8, 2025TEVA PHARMACEUTICALS
Anticancer CompositionsARAGON PHARMACEUTICALSJul 7, 2025ZENTIVA KS
Use Of Riluzole Prodrugs To Treat AtaxiasBIOHAVEN PHARMACEUTICAL HOLDINGJul 2, 2025KRAUS & LEDERER PARTGMBB
Methods For Reducing Lipoprotein(A) Levels By Administering An Inhibitor Of Proprotein Convertase Subtilisin Kexin-9 (Pcsk9)REGENERON PHARMACEUTICALSJun 23, 2025AMGEN
Method Of Treating Or Ameliorating Metabolic Disorders Using Glp-1 Receptor Agonists Conjugated To Antagonists For Gastric Inhibitory Peptide Receptor (Gipr)AMGENJun 18, 2025JG OPPOSITIONS

To stay ahead in the competitive Metabolic Drugs industry, companies are constantly innovating. Here are the top patents facing oppositions in the Metabolic Drugs industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
Apr 14, 2021Methods And Compositions For Treating CancerJANSSEN ONCOLOGY22
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE15
Mar 10, 2021Novel Antitumoral Use Of CabazitaxelSANOFI MATURE13
Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA11
Aug 18, 2021Formulations Of EnzalutamideASTELLAS PHARMA11
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA THERAPEUTICS10
Sep 14, 2022Therapeutic Uses Of EmpagliflozinBOEHRINGER INGELHEIM10
Aug 21, 2019Rapamycin Derivative For Treating Pancreas CancerNOVARTIS10